Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012045
Filing Date
2025-05-05
Accepted
2025-05-05 19:30:05
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05052025_070501.html 4  
1 form4-05052025_070501.xml 4 6040
  Complete submission text file 0001415889-25-012045.txt   7546
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 151 W 42 ST 14TH FLOOR NEW YORK NY 10036
Business Address
Susman Robert Graham (Reporting) CIK: 0002065992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 25914684